Clinical Trials for Mitsubishi Tanabe Pharma

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Mitsubishi Tanabe Pharma

Clinical Trials (7)

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

PHASE1/PHASE2Recruiting

27 participants

Started: Apr 18, 2025 · Completed: Aug 31, 2028

16 conditions1 sponsor6 locations

An Exploratory Study of MT-2990 in Patients With AAV

PHASE1Active, not recruiting

10 participants

Started: Jun 24, 2024 · Completed: Feb 28, 2026

1 condition1 sponsor8 locations

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

PHASE3Active, not recruiting

165 participants

Started: Dec 11, 2023 · Completed: Jun 30, 2026

2 conditions1 sponsor36 locations

A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL

PHASE1/PHASE2Active, not recruiting

46 participants

Started: Jan 30, 2023 · Completed: Aug 31, 2028

1 condition1 sponsor23 locations

A Study of MT-0551 in Patients With Systemic Sclerosis

PHASE3Active, not recruiting

80 participants

Started: Jul 20, 2022 · Completed: Aug 31, 2026

1 condition1 sponsor4 locations

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

PHASE3Recruiting

301 participants

Started: Aug 10, 2021 · Completed: Dec 31, 2027

2 conditions1 sponsor51 locations

Analysis of Human ALS Tissues and Registry of ALS Patients

40 participants

Started: Sep 1, 2020 · Completed: Jan 1, 2030

1 condition2 sponsors1 location